{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T09:26:06Z","timestamp":1786872366619,"version":"build-2736575974"},"reference-count":64,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA239178"],"award-info":[{"award-number":["R01CA239178"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA239178"],"award-info":[{"award-number":["R01CA239178"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The marketing of heated tobacco products (HTPs), like IQOS, influences consumers\u2019 perceptions. This mixed-methods study analyzed (i) survey data (2021) of 2222 US and Israeli adults comparing perceptions of 7 IQOS attributes (design, technology, colors, customization, flavors, cost and maintenance) and 10 marketing messages (e.g. \u2018Go smoke-free\u2026\u2019) across tobacco use subgroups and (ii) qualitative interviews (n\u2009=\u200984) regarding IQOS perceptions. In initial bivariate analyses, those never using HTPs (86.2%) reported the least overall appeal; those currently using HTPs (7.7%) reported the greatest appeal. Notably, almost all (94.8%) currently using HTPs also currently used cigarettes (82.0%) and\/or e-cigarettes (64.0%). Thus, multivariable linear regression accounted for current cigarette\/e-cigarette use subgroup and HTP use separately; compared to neither cigarette\/e-cigarette use (62.8%), cigarette\/no e-cigarette use (17.1%) and e-cigarette\/no cigarette use (6.5%), those with dual use (13.5%) indicated greater overall IQOS appeal (per composite index score); current HTP use was not associated. Qualitative data indicated varied perceptions regarding advantages (e.g. harm, addiction and complexity) of IQOS versus cigarettes and e-cigarettes, and perceived target markets included young people, those looking for cigarette alternatives and females. Given the perceived target markets and particular appeal to dual cigarette\/e-cigarette use groups, IQOS marketing and population impact warrant ongoing monitoring to inform regulation.<\/jats:p>","DOI":"10.1093\/her\/cyae018","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T20:51:43Z","timestamp":1713387103000},"page":"375-397","source":"Crossref","is-referenced-by-count":4,"title":["Heated tobacco product marketing: a mixed-methods study examining exposure and perceptions among US and Israeli adults"],"prefix":"10.1093","volume":"39","author":[{"given":"Yuxian","family":"Cui","sequence":"first","affiliation":[{"name":"Department of Prevention and Community Health, Milken Institute School of Public Health, George Washington University , 950 New Hampshire Avenue, Washington, DC 20052,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Bar-Zeev","sequence":"additional","affiliation":[{"name":"Braun School of Public Health and Community Medicine, Faculty of Medicine, The Hebrew University of Jerusalem and Hadassah Medical Center , 7 Ramat Gan, Jerusalem, 9112102,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagai","family":"Levine","sequence":"additional","affiliation":[{"name":"Braun School of Public Health and Community Medicine, Faculty of Medicine, The Hebrew University of Jerusalem and Hadassah Medical Center , 7 Ramat Gan, Jerusalem, 9112102,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4206-4179","authenticated-orcid":false,"given":"Cassidy R","family":"LoParco","sequence":"additional","affiliation":[{"name":"Department of Prevention and Community Health, Milken Institute School of Public Health, George Washington University , 950 New Hampshire Avenue, Washington, DC 20052,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2598-1752","authenticated-orcid":false,"given":"Zongshuan","family":"Duan","sequence":"additional","affiliation":[{"name":"School of Public Health, Georgia State University , 140 Decatur St. SE, Atlanta, GA 30303,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[{"name":"GW Cancer Center, George Washington University , 800 22nd Street NW, Washington, DC 20052,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorien C","family":"Abroms","sequence":"additional","affiliation":[{"name":"GW Cancer Center, George Washington University , 800 22nd Street NW, Washington, DC 20052,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0525-4889","authenticated-orcid":false,"given":"Amal","family":"Khayat","sequence":"additional","affiliation":[{"name":"Braun School of Public Health and Community Medicine, Faculty of Medicine, The Hebrew University of Jerusalem and Hadassah Medical Center , 7 Ramat Gan, Jerusalem, 9112102,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8931-1961","authenticated-orcid":false,"given":"Carla J","family":"Berg","sequence":"additional","affiliation":[{"name":"GW Cancer Center, George Washington University , 800 22nd Street NW, Washington, DC 20052,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,5,13]]},"reference":[{"key":"2026081605062652500_R1","article-title":"Public Health Consequences of E-Cigarettes","volume-title":"Report No.: 0309468345","author":"National Academies of Sciences, Engineering, and Medicine","year":"2018"},{"key":"2026081605062652500_R2","article-title":"Tobacco Free Initiative (TFI): Heat-Not-Burn Tobacco Products Information Sheet","author":"World Health Organization","year":"2020"},{"key":"2026081605062652500_R3","doi-asserted-by":"crossref","DOI":"10.1177\/2158244019898823","article-title":"Informing iQOS regulations in the United States: a synthesis of what we know","volume":"10","author":"Berg","year":"2020","journal-title":"SAGE Open"},{"key":"2026081605062652500_R4","article-title":"Heated Tobacco Products","author":"US Centers for Disease Control and Prevention","year":"2021"},{"key":"2026081605062652500_R5","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1136\/tc-2022-057285","article-title":"Brief report on IQOS point-of-sale marketing, promotion and pricing in IQOS retail partner stores in Atlanta, Georgia, USA","volume":"32","author":"Henderson","year":"2023","journal-title":"Tob Control"},{"key":"2026081605062652500_R6","article-title":"Exposure Modification Modified Risk Granted Orders, FDA Submission Tracking Numbers (STNs): MR0000059-MR0000061, MR0000133, 2020","author":"US Food and Drug Administration"},{"key":"2026081605062652500_R7","article-title":"Philip Morris IQOS Imports Barred from U.S.; Deadline Passes","author":"Gretler","year":"2021"},{"key":"2026081605062652500_R8","article-title":"Philip Morris Plans U.S. IQOS-Stick Production after Import Ban","volume-title":"Bloomberg News","author":"Gretler","year":"2022"},{"key":"2026081605062652500_R9","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1093\/ntr\/ntad096","article-title":"IQOS marketing strategies and expenditures in the United States from market entrance in 2019 to withdrawal in 2021","volume":"25","author":"Duan","year":"2023","journal-title":"Nicotine Tob Res"},{"key":"2026081605062652500_R10","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph20043141","article-title":"IQOS use and interest by sociodemographic and tobacco behavior characteristics among adults in the US and Israel","volume":"20","author":"Levine","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"2026081605062652500_R11","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1093\/ntr\/ntac185","article-title":"Correlates of perceptions, use, and intention to use heated tobacco products among US young adults in 2020","volume":"24","author":"Duan","year":"2022","journal-title":"Nicotine Tob Res"},{"key":"2026081605062652500_R12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/tobaccocontrol-2017-054216","article-title":"Marketing IQOS in a dark market","volume":"28","author":"Mathers","year":"2019","journal-title":"Tob Control"},{"key":"2026081605062652500_R13","doi-asserted-by":"crossref","DOI":"10.1186\/s13584-019-0316-6","article-title":"Point-of-sale marketing of heated tobacco products in Israel: cause for concern","volume":"8","author":"Halpern-Felsher","year":"2019","journal-title":"Isr J Health Policy Res"},{"key":"2026081605062652500_R14","first-page":"e152","article-title":"IQOS debut in the USA: Philip Morris International\u2019s heated tobacco device introduced in Atlanta, Georgia","volume":"29","author":"Churchill","year":"2020","journal-title":"Tob Control"},{"key":"2026081605062652500_R15","doi-asserted-by":"crossref","first-page":"e198","DOI":"10.1136\/tobaccocontrol-2021-057083","article-title":"IQOS marketing strategies at point-of-sales: a cross-sectional survey with retailers","volume":"32","author":"Bar-Zeev","year":"2023","journal-title":"Tob Control"},{"key":"2026081605062652500_R16","article-title":"Industry marketing of tobacco products on social media: case study of Philip Morris International\u2019s IQOS","author":"Abroms","year":"2023","journal-title":"Tob Control"},{"key":"2026081605062652500_R17","first-page":"67","article-title":"Promotion of tobacco products on Facebook: policy versus practice","volume":"28","author":"Jackler","year":"2019","journal-title":"Tob Control"},{"key":"2026081605062652500_R18","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/tobaccocontrol-2021-056819","article-title":"IQOS marketing strategies in the USA before and after US FDA modified risk tobacco product authorisation","volume":"32","author":"Berg","year":"2023","journal-title":"Tob Control"},{"key":"2026081605062652500_R19","article-title":"Heated tobacco products (HTPs) market monitoring information sheet, 2018","author":"World Health Organization"},{"key":"2026081605062652500_R20","doi-asserted-by":"crossref","DOI":"10.1186\/s12954-021-00490-8","article-title":"\u2018I perceive it to be less harmful, I have no idea if it is or not:\u2019 a qualitative exploration of the harm perceptions of IQOS among adult users","volume":"18","author":"East","year":"2021","journal-title":"Harm Reduct J"},{"key":"2026081605062652500_R21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/tobaccocontrol-2021-056479","article-title":"Effect of a hypothetical modified risk tobacco product claim on heated tobacco product use intention and perceptions in young adults","volume":"32","author":"Chen-Sankey","year":"2023","journal-title":"Tob Control"},{"key":"2026081605062652500_R22","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.109136","article-title":"Awareness, use and perceptions of cigarillos, heated tobacco products and nicotine pouches: a survey among Dutch adolescents and adults","volume":"229","author":"Havermans","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"2026081605062652500_R23","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/her\/cyac019","article-title":"\u2018It\u2019s like if a vape pen and a cigarette had a baby\u2019: a mixed methods study of perceptions and use of IQOS among US young adults","volume":"37","author":"Duan","year":"2022","journal-title":"Health Ed Res"},{"key":"2026081605062652500_R24","doi-asserted-by":"crossref","DOI":"10.1038\/s41533-023-00333-y","article-title":"Romanian young adult perceptions on using heated tobacco products following exposure to direct marketing methods","volume":"33","author":"Chirila","year":"2023","journal-title":"NPJ Prim Care Respir Med"},{"key":"2026081605062652500_R25","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph192214632","article-title":"Do young people perceive e-cigarettes and heated tobacco as less harmful than traditional cigarettes? A survey from Poland","volume":"19","author":"W\u0119\u017cyk-Caba","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"2026081605062652500_R26","doi-asserted-by":"crossref","first-page":"s62","DOI":"10.1136\/tobaccocontrol-2018-054315","article-title":"Impact of modified risk tobacco product claims on beliefs of US adults and adolescents","volume":"27","author":"El-Toukhy","year":"2018","journal-title":"Tob Control"},{"key":"2026081605062652500_R27","doi-asserted-by":"crossref","DOI":"10.1016\/j.pmedr.2023.102209","article-title":"Impact of different health warning label and reduced exposure messages in IQOS ads on perceptions among US and Israeli adults","author":"Berg","year":"2023","journal-title":"Prev Med Rep"},{"key":"2026081605062652500_R28","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1136\/tc-2022-057639","article-title":"Impact of FDA endorsement and modified risk versus exposure messaging in IQOS ads: a randomised factorial experiment among US and Israeli adults","volume":"33","author":"Berg","year":"2024","journal-title":"Tob Control"},{"key":"2026081605062652500_R29","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1136\/tobaccocontrol-2020-056191","article-title":"Effects of modified risk tobacco product claims on consumer comprehension and risk perceptions of IQOS","volume":"31","author":"Yang","year":"2022","journal-title":"Tob Control"},{"key":"2026081605062652500_R30","first-page":"e18","article-title":"PMI\u2019s heated tobacco products marketing claims of reduced risk and reduced exposure may entice youth to try and continue using these products","volume":"29","author":"McKelvey","year":"2020","journal-title":"Tob Control"},{"key":"2026081605062652500_R31","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1136\/tobaccocontrol-2020-056041","article-title":"Tobacco legislation reform and industry response in Israel","volume":"30","author":"Bar-Zeev","year":"2021","journal-title":"Tob Control"},{"key":"2026081605062652500_R32","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/add.13231","article-title":"Awareness and use of electronic cigarettes and heat-not-burn tobacco products in Japan","volume":"111","author":"Tabuchi","year":"2016","journal-title":"Addiction"},{"key":"2026081605062652500_R33","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1136\/tobaccocontrol-2016-053264","article-title":"Heat-not-burn tobacco products are about to reach their boiling point","volume":"26","author":"Caputi","year":"2017","journal-title":"Tob Control"},{"key":"2026081605062652500_R34","doi-asserted-by":"crossref","first-page":"s70","DOI":"10.1136\/tobaccocontrol-2018-054322","article-title":"Examining perceptions about IQOS heated tobacco product: consumer studies in Japan and Switzerland","volume":"27","author":"Hair","year":"2018","journal-title":"Tob Control"},{"key":"2026081605062652500_R35","article-title":"Philip Morris International Announces U.S. Food and Drug Administration Authorization for Sale of IQOS in the United States","author":"Philip Morris International"},{"key":"2026081605062652500_R36","article-title":"FDA permits sale of IQOS Tobacco Heating System through premarket tobacco product application pathway","author":"US Food and Drug Administration","year":"2019"},{"key":"2026081605062652500_R37","article-title":"Marketing Order, FDA Submission Tracking Numbers (STNs): PM0000424-PM0000426, PM0000479, IQOS System Holder and Charger and Marlboro Heatsticks","author":"US Food and Drug Administration","year":"2019"},{"key":"2026081605062652500_R38","doi-asserted-by":"crossref","first-page":"s55","DOI":"10.1136\/tobaccocontrol-2018-054323","article-title":"Awareness and use of heated tobacco products among US adults, 2016\u20132017","volume":"27","author":"Nyman","year":"2018","journal-title":"Tob Control"},{"key":"2026081605062652500_R39","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/ntr\/ntab058","article-title":"Heated tobacco product awareness, use, and perceptions in a sample of young adults in the U.S","volume":"23","author":"Berg","year":"2021","journal-title":"Nicotine Tob Res"},{"key":"2026081605062652500_R40","first-page":"113","article-title":"Heat-not-burn tobacco products: concerns from the Italian experience","volume":"28","author":"Liu","year":"2019","journal-title":"Tob Control"},{"key":"2026081605062652500_R41","doi-asserted-by":"crossref","first-page":"s74","DOI":"10.1136\/tobaccocontrol-2018-054390","article-title":"Awareness, experience and prevalence of heated tobacco product, IQOS, among young Korean adults","volume":"27","author":"Kim","year":"2018","journal-title":"Tob Control"},{"key":"2026081605062652500_R42","article-title":"IQOS Marketing Examples: Campaign for Tobacco-Free Kids","author":"Campaign for Tobacco-Free Kids","year":"2018"},{"key":"2026081605062652500_R43","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/tobaccocontrol-2018-054654","article-title":"Awareness and interest in IQOS heated tobacco products among youth in Canada, England and the USA","volume":"29","author":"Czoli","year":"2020","journal-title":"Tob Control"},{"key":"2026081605062652500_R44","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1136\/tc-2022-057671","article-title":"PMI\u2019s IQOS and cigarette ads in Israeli media: a content analysis across regulatory periods and target population subgroups","volume":"33","author":"Khayat","year":"2024","journal-title":"Tob Control"},{"key":"2026081605062652500_R45","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/ntr\/ntab142","article-title":"Assessment of IQOS marketing strategies at points-of-sale in Israel at a time of regulatory transition","volume":"24","author":"Bar-Zeev","year":"2022","journal-title":"Nicotine Tob Res"},{"key":"2026081605062652500_R46","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1136\/tc-2022-057585","article-title":"IQOS and cigarette advertising across regulatory periods and population groups in Israel: a longitudinal analysis","volume":"33","author":"Khayat","year":"2024","journal-title":"Tob Control"},{"key":"2026081605062652500_R47","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1111\/1475-6773.12117","article-title":"Achieving integration in mixed methods designs-principles and practices","volume":"48","author":"Fetters","year":"2013","journal-title":"Health Serv Res"},{"key":"2026081605062652500_R48","doi-asserted-by":"crossref","first-page":"475","DOI":"10.15585\/mmwr.mm7218a1","article-title":"Tobacco product use among adults\u2014United States, 2021","volume":"72","author":"Cornelius","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026081605062652500_R49","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2188\/jea.JE20200248","article-title":"Use and awareness of heated tobacco products in Europe","volume":"32","author":"Gallus","year":"2022","journal-title":"J Epidemiol"},{"key":"2026081605062652500_R50","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/ntr\/ntab217","article-title":"Characterizing heated tobacco product use among adult cigarette smokers and nicotine vaping product users in the 2018 ITC four country smoking & vaping survey","volume":"24","author":"Miller","year":"2021","journal-title":"Nicotine Tob Res"},{"key":"2026081605062652500_R51","article-title":"International Tobacco Control Policy Evaluation Project: 4-Country Smoking & Vaping W3","author":"International Tobacco Control Policy Evaluation Project","year":"2020"},{"key":"2026081605062652500_R52","article-title":"Global Adult Tobacco Survey (GATS): Sample Design Manual","author":"Global Adult Tobacco Survey Collaborative Group","year":"2020"},{"key":"2026081605062652500_R53","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qual Res Psychol"},{"key":"2026081605062652500_R54","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1136\/tobaccocontrol-2013-051437","article-title":"\u2018Vape shops\u2019 and \u2018E-Cigarette lounges\u2019 open across the USA to promote ENDS","volume":"24","author":"Lee","year":"2015","journal-title":"Tob Control"},{"key":"2026081605062652500_R55","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/tobaccocontrol-2011-050416","article-title":"Comprehensive tobacco marketing restrictions: promotion, packaging, price and place","volume":"21","author":"Henriksen","year":"2012","journal-title":"Tob Control"},{"key":"2026081605062652500_R56","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18126651","article-title":"Exposure to heated tobacco products and adverse health effects, a systematic review","volume":"18","author":"Znyk","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"2026081605062652500_R57","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph181910551","article-title":"IQOS marketing in the US: the need to study the impact of FDA modified exposure authorization, marketing distribution channels, and potential targeting of consumers","volume":"18","author":"Berg","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"2026081605062652500_R58","doi-asserted-by":"crossref","first-page":"s87","DOI":"10.1136\/tobaccocontrol-2018-054324","article-title":"Light and mild redux: heated tobacco products\u2019 reduced exposure claims are likely to be misunderstood as reduced risk claims","volume":"27","author":"Popova","year":"2018","journal-title":"Tob Control"},{"key":"2026081605062652500_R59","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/tobaccocontrol-2015-052656","article-title":"Packaging colour research by tobacco companies: the pack as a product characteristic","volume":"26","author":"Lempert","year":"2017","journal-title":"Tob Control"},{"key":"2026081605062652500_R60","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.amepre.2011.01.019","article-title":"What do cigarette pack colors communicate to smokers in the US?","volume":"40","author":"Bansal-Travers","year":"2011","journal-title":"Am J Prev Med"},{"key":"2026081605062652500_R61","doi-asserted-by":"crossref","first-page":"ii20","DOI":"10.1136\/tc.2010.041939","article-title":"Marketing of menthol cigarettes and consumer perceptions: a review of tobacco industry documents","volume":"20","author":"Anderson","year":"2011","journal-title":"Tob Control"},{"key":"2026081605062652500_R62","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.amepre.2011.01.021","article-title":"The impact of cigarette pack design, descriptors, and warning labels on risk perception in the US","volume":"40","author":"Bansal-Travers","year":"2011","journal-title":"Am J Prev Med"},{"key":"2026081605062652500_R63","article-title":"STEPwise approach to NCD risk factor surveillance (STEPS)","author":"World Health Organization","year":"2023"},{"key":"2026081605062652500_R64","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/jcad.12365","article-title":"Promoting rigorous research: generalizability and qualitative research","volume":"99","author":"Hays","year":"2021","journal-title":"J Counseling Dev"}],"container-title":["Health Education Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/her\/article-pdf\/39\/4\/375\/59114578\/cyae018.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/her\/article-pdf\/39\/4\/375\/59114578\/cyae018.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T09:06:46Z","timestamp":1786871206000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/her\/article\/39\/4\/375\/7671020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,13]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7,18]]}},"URL":"https:\/\/doi.org\/10.1093\/her\/cyae018","relation":{},"ISSN":["0268-1153","1465-3648"],"issn-type":[{"value":"0268-1153","type":"print"},{"value":"1465-3648","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,8]]},"published":{"date-parts":[[2024,5,13]]}}}